---
title: "Top 10 港股跌幅（6月25日）"
description: "康宁杰瑞制药-B(09966) 跌 12.17%，成交额 4597.5 万港元，年内累计涨 79.4%。 浙江世宝 (01057) 跌 12.15%，成交额 9.3 亿港元，年内累计涨 94.4%。 来凯医药-B(02105) 跌 9.14%，成交额 1.5 亿港元，年内累计涨 91%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/246037482.md"
published_at: "2025-06-25T08:30:51.000Z"
---

# Top 10 港股跌幅（6月25日）

> 康宁杰瑞制药-B(09966) 跌 12.17%，成交额 4597.5 万港元，年内累计涨 79.4%。 浙江世宝 (01057) 跌 12.15%，成交额 9.3 亿港元，年内累计涨 94.4%。 来凯医药-B(02105) 跌 9.14%，成交额 1.5 亿港元，年内累计涨 91%。

恒生指数涨 1.23%，年内累计涨 22%；恒生科技指数涨 1.15%，年内累计涨 19.9%。

康宁杰瑞制药-B(09966) 跌 12.17%，成交额 4597.5 万港元，年内累计涨 79.4%。

浙江世宝 (01057) 跌 12.15%，成交额 9.3 亿港元，年内累计涨 94.4%。

来凯医药-B(02105) 跌 9.14%，成交额 1.5 亿港元，年内累计涨 91%。

### Related Stocks

- [09966.HK - 康宁杰瑞制药-B](https://longbridge.com/zh-CN/quote/09966.HK.md)
- [01057.HK - 浙江世宝](https://longbridge.com/zh-CN/quote/01057.HK.md)
- [02105.HK - 来凯医药-B](https://longbridge.com/zh-CN/quote/02105.HK.md)
- [00340.HK - 潼关黄金](https://longbridge.com/zh-CN/quote/00340.HK.md)
- [02169.HK - 沧港铁路](https://longbridge.com/zh-CN/quote/02169.HK.md)
- [03933.HK - 联邦制药](https://longbridge.com/zh-CN/quote/03933.HK.md)
- [02367.HK - 巨子生物](https://longbridge.com/zh-CN/quote/02367.HK.md)
- [02489.HK - 集海黄金](https://longbridge.com/zh-CN/quote/02489.HK.md)
- [02587.HK - 健康之路](https://longbridge.com/zh-CN/quote/02587.HK.md)
- [02633.HK - 雅各臣科研制药](https://longbridge.com/zh-CN/quote/02633.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| HealthyWay Forecasts Return to Profit in 2025 | HealthyWay Forecasts Return to Profit in 2025 | [Link](https://longbridge.com/zh-CN/news/275840763.md) |
| Persistence Gold Halts Yantai Output but Presses Ahead With Global Expansion Plans | Persistence Resources Group Ltd has temporarily halted production at its Yantai gold mining subsidiaries due to a local  | [Link](https://longbridge.com/zh-CN/news/275468188.md) |
| TUL Roxithromycin Capsules Gain China Consistency Evaluation Approval | The United Laboratories International Holdings Limited (TUL) announced that its subsidiary has received approval from th | [Link](https://longbridge.com/zh-CN/news/275299526.md) |
| Tongguan Gold Group Announces Partial Conversion of Convertible Bond, Issues 6 Million New Shares | Tongguan Gold Group Ltd. has announced the partial conversion of its convertible bond by Tongfei Investment Limited, res | [Link](https://longbridge.com/zh-CN/news/273958142.md) |
| FDA Approves IND Application for TUL108 Injection from The United Laboratories | The United Laboratories International Holdings Limited announced that its subsidiary, Zhuhai United Laboratories Co., Lt | [Link](https://longbridge.com/zh-CN/news/273983115.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。